Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ.
Jiang C, et al. Among authors: xie c.
J Clin Invest. 2015 Jan;125(1):386-402. doi: 10.1172/JCI76738. Epub 2014 Dec 15.
J Clin Invest. 2015.
PMID: 25500885
Free PMC article.